| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2007 ( Subtotal = $15,336,618 ) |
| | 2007 | 2007 | CANCER THERAPY & RESEARCH CENTER | 7979 WURZBACH URSCHEL TOWER | SAN ANTONIO | TX | 78229 | BEXAR | USA | U01CA077178 | SELENIUM BASED CHEMOPREVENTION - HGPIN | 000 | 11 | NIH | 8/24/2007 | $1 |
| | 2007 | 2007 | CANCER THERAPY & RESEARCH CENTER | 7979 WURZBACH URSCHEL TOWER | SAN ANTONIO | TX | 78229 | BEXAR | USA | U10CA037429 | SWOG Community Clinical Oncology Program Research Base | 001 | 22 | NIH | 9/7/2007 | $500,000 |
| | 2007 | 2007 | CANCER THERAPY & RESEARCH CENTER | 7979 WURZBACH URSCHEL TOWER | SAN ANTONIO | TX | 78229 | BEXAR | USA | U10CA037429 | SWOG Community Clinical Oncology Program Research Base | 000 | 22 | NIH | 8/17/2007 | $14,335,283 |
| | 2007 | 2007 | CANCER THERAPY & RESEARCH CENTER | 7979 WURZBACH URSCHEL TOWER | SAN ANTONIO | TX | 78229 | BEXAR | USA | U01CA069853 | PHASE I CLINICAL TRIALS OF ANTI-CANCER AGENTS | 000 | 13 | NIH | 3/26/2007 | $501,334 |
|
| Issue Date FY: 2006 ( Subtotal = $16,607,691 ) |
| | 2006 | 2006 | CANCER THERAPY & RESEARCH CENTER | 7979 WURZBACH URSCHEL TOWER | SAN ANTONIO | TX | 78229 | BEXAR | USA | U01CA077178 | SELENIUM BASED CHEMOPREVENTION - HGPIN | 000 | 10 | NIH | 9/14/2006 | $0 |
| | 2006 | 2006 | CANCER THERAPY & RESEARCH CENTER | 7979 WURZBACH URSCHEL TOWER | SAN ANTONIO | TX | 78229 | BEXAR | USA | U10CA037429 | SWOG Community Clinical Oncology Program Research Base | 002 | 21 | NIH | 7/28/2006 | $15,610,103 |
| | 2006 | 2006 | CANCER THERAPY & RESEARCH CENTER | 7979 WURZBACH URSCHEL TOWER | SAN ANTONIO | TX | 78229 | BEXAR | USA | U10CA037429 | SWOG Community Clinical Oncology Program Research Base | 003 | 21 | NIH | 9/7/2006 | $500,000 |
| | 2006 | 2006 | CANCER THERAPY & RESEARCH CENTER | 7979 WURZBACH URSCHEL TOWER | SAN ANTONIO | TX | 78229 | BEXAR | USA | U01CA069853 | PHASE I CLINICAL TRIALS OF ANTI-CANCER AGENTS | 000 | 12 | NIH | 2/23/2006 | $497,588 |
|
| Issue Date FY: 2004 ( Subtotal = $28,245,287 ) |
| | 2004 | 2004 | CANCER THERAPY & RESEARCH CENTER | 7979 WURZBACH URSCHEL TOWER | SAN ANTONIO | TX | 78229 | BEXAR | USA | U10CA037429 | SWOG Community Clinical Oncology Program Research Base | 000 | 20 | NIH | 8/11/2004 | $14,905,141 |
| | 2004 | 2004 | CANCER THERAPY & RESEARCH CENTER | 7979 WURZBACH URSCHEL TOWER | SAN ANTONIO | TX | 78229 | BEXAR | USA | U10CA032102 | Southwest Oncology Group Treatment Grant | 000 | 24 | NIH | 8/9/2004 | $9,431,895 |
| | 2004 | 2004 | CANCER THERAPY & RESEARCH CENTER | 7979 WURZBACH URSCHEL TOWER | SAN ANTONIO | TX | 78229 | BEXAR | USA | U10CA037429 | SWOG Community Clinical Oncology Program Research Base | 001 | 20 | NIH | 9/15/2004 | $3,416,212 |
| | 2004 | 2004 | CANCER THERAPY & RESEARCH CENTER | 7979 WURZBACH URSCHEL TOWER | SAN ANTONIO | TX | 78229 | BEXAR | USA | U01CA077178 | SELENIUM BASED CHEMOPREVENTION - HGPIN | 000 | 8 | NIH | 9/2/2004 | $0 |
| | 2004 | 2004 | CANCER THERAPY & RESEARCH CENTER | 7979 WURZBACH URSCHEL TOWER | SAN ANTONIO | TX | 78229 | BEXAR | USA | U01CA069853 | PHASE I CLINICAL TRIALS OF ANTI-CANCER AGENTS | 000 | 10 | NIH | 3/29/2004 | $492,039 |
|
|
